UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A Growing and Aging Cohort With Rising Mortality

Sundaram, V; Jalan, R; Shah, P; Singal, AK; Patel, AA; Wu, T; Noureddin, M; ... Wong, RJ; + view all (2021) Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A Growing and Aging Cohort With Rising Mortality. Hepatology , 73 (5) pp. 1932-1944. 10.1002/hep.31566. Green open access

[thumbnail of hep.31566.pdf]
Preview
Text
hep.31566.pdf - Accepted Version

Download (15MB) | Preview

Abstract

We assessed the burden of nonalcoholic fatty liver disease (NAFLD) related acute on chronic liver failure (ACLF) among transplant candidates in the United States (US), along with waitlist outcomes for this population. We analyzed the United Network for Organ Sharing (UNOS) registry from 2005‐2017. Patients with ACLF were identified using the EASL‐CLIF criteria and categorized into NAFLD, alcoholic liver disease (ALD), and hepatitis C virus (HCV) infection. We used linear regression and Chow's test to determine significance in trends and evaluated waitlist outcomes using Fine and Gray's competing risks regression and Cox proportional hazards regression. Between 2005 and 2017, waitlist registrants for NAFLD‐ACLF rose by 331.6% from 134 to 574 candidates (p<0.001), representing the largest percentage increase in the study population. ALD‐ACLF also increased by 206.3% (348 to 1,066 registrants, p<0.001), while HCV‐ACLF declined by 45.2% (p<0.001). As of 2017, the NAFLD‐ACLF population consisted primarily of individuals age 60 or older (54.1%), and linear regression demonstrated a significant rise in the proportion of patients age ≥ 65 in this group (β=0.90, p=0.011). Since 2014, NAFLD‐ACLF grade 1 was associated with a greater risk of waitlist mortality relative to ALD‐ACLF (SHR=1.24, 95% CI 1.05‐1.44) and HCV‐ACLF (SHR=1.35, 95% CI 1.08‐1.71), among patients ≥ 60 years old. Mortality was similar among the three groups for patients with ACLF grade 2 or 3. / Conclusion: NAFLD is the fastest rising etiology of cirrhosis associated with ACLF among patients listed in the US. As the NAFLD population continues to grow and age, patients with NAFLD‐ACLF will likely have the highest risk of waitlist mortality.

Type: Article
Title: Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A Growing and Aging Cohort With Rising Mortality
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/hep.31566
Publisher version: https://doi.org/10.1002/hep.31566
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: MELD-Na score, UNOS database, organ failure
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inst for Liver and Digestive Hlth
URI: https://discovery.ucl.ac.uk/id/eprint/10111531
Downloads since deposit
227Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item